1. Kikuchi Y, Seta K, Ogawa Y, Takayama T, Nagata M, Taguchi T, et al. Chaga mushroom-induced oxalate nephropathy. Clin Nephrol. 2014; 81(6):440–444. PMID:
23149251.
Article
2. Lumlertgul N, Siribamrungwong M, Jaber BL, Susantitaphong P. Secondary Oxalate Nephropathy: A Systematic Review. Kidney Int Rep. 2018; 3(6):1363–1372. PMID:
30450463.
3. Sasaki M, Murakami M, Matsuo K, Matsuo Y, Tanaka S, Ono T, et al. Oxalate nephropathy with a granulomatous lesion due to excessive intake of peanuts. Clin Exp Nephrol. 2008; 12(4):305–308. PMID:
18335167.
Article
4. Lewandowski S, Rodgers A, Schloss I. The influence of a high-oxalate/low-calcium diet on calcium oxalate renal stone risk factors in non-stone-forming black and white South African subjects. BJU Int. 2001; 87(4):307–311. PMID:
11251520.
Article
5. Lewandowski S, Rodgers AL, Laube N, von Unruh G, Zimmermann D, Hesse A. Oxalate and its handling in a low stone risk vs a stone-prone population group. World J Urol. 2005; 23(5):330–333. PMID:
16283325.
Article
6. Beier RC. Natural pesticides and bioactive components in foods. Rev Environ Contam Toxicol. 1990; 113:47–137. PMID:
2404325.
Article
7. Glew RH, Sun Y, Horowitz BL, Konstantinov KN, Barry M, Fair JR, et al. Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease. World J Nephrol. 2014; 3(4):122–142. PMID:
25374807.
Article
8. Glamočlija J, Ćirić A, Nikolić M, Fernandes Â, Barros L, Calhelha RC, et al. Chemical characterization and biological activity of Chaga (Inonotus obliquus), a medicinal “mushroom”. J Ethnopharmacol. 2015; 162:323–332. PMID:
25576897.
Article
9. Shashkina MY, Shashkin PN, Sergeev AV. Chemical and medicobiological properties of chaga. [review]. Pharm Chem J. 2006; 40(10):560–568.
10. Chen CL, Fang HC, Chou KJ, Wang JS, Chung HM. Acute oxalate nephropathy after ingestion of star fruit. Am J Kidney Dis. 2001; 37(2):418–422. PMID:
11157385.
Article
11. Asano Y, Jinnin M, Kawaguchi Y, Kuwana M, Goto D, Sato S, et al. Diagnostic criteria, severity classification and guidelines of systemic sclerosis. J Dermatol. 2018; 45(6):633–691. PMID:
29687465.
Article
12. Hoppe B. An update on primary hyperoxaluria. Nat Rev Nephrol. 2012; 8(8):467–475. PMID:
22688746.
Article